A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

CAM-3001

A single patient shall be dosed with a dose of 0.01mg/kg of CAM-3001 followed no sooner than 24 hours later by a second patient at a dose of 0.03mg/kg.

DRUG

CAM-3001

Dosed at 0.1mg/kg.

DRUG

CAM-3001

Dosed at 0.3mg/kg

DRUG

CAM-3001

Dosed at 1.0 mg/kg.

DRUG

CAM-3001

Dosed at 3.0 mg/kg.

DRUG

CAM-3001

Dosed at 10 mg/kg.

OTHER

Placebo

Active: Placebo 5:1 for arms 2-6

Trial Locations (1)

10117

Charite Research Organization GmbH, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MedImmune Ltd

INDUSTRY